People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Origen Therapeutics Inc /Ca | — | Biotechnology | Seed | $3.7M | $166.2M | 2010 |
Robert W. Kay at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert W. Kay on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David W. Carter | 1 | 2 |
| Spencer W. Wang | 1 | 1 |
| Timothy W. Harris | 1 | 1 |
| Lynda W. Wijcik | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.